[Proceedings: Changes in renin-angiotensin system in essential hypertension and thyroid diseases]. 1974

T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D013959 Thyroid Diseases Pathological processes involving the THYROID GLAND. Disease, Thyroid,Diseases, Thyroid,Thyroid Disease

Related Publications

T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
October 1979, Nihon rinsho. Japanese journal of clinical medicine,
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
August 1975, Lancet (London, England),
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
October 2007, Public health nutrition,
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
May 1975, Horumon to rinsho. Clinical endocrinology,
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
November 1973, Nihon rinsho. Japanese journal of clinical medicine,
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
January 1975, Kardiologia polska,
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
April 1975, Medizinische Klinik,
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
January 1973, Acta physiologica latino americana,
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
July 1995, Current opinion in nephrology and hypertension,
T Saito, and Y Masuda, and T Ozawa, and M Endo, and H Murayama
October 1976, Lakartidningen,
Copied contents to your clipboard!